MAPT and Alzheimer disease: Plasma p-tau concentrations increase gradually along the sporadic AD continuum in relation to the severity of Aβ pathology and cognitive function, reaching the highest concentrations in Aβ + participants with MCI and AD dementia [19, 41, 43–45, 47, 58, 62, 72, 73].